Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10918000 | Radiotherapy and Oncology | 2014 | 8 Pages |
Abstract
The major strength of DWI and 18F-FDG PET/CT lies in the identification of non-responders who are not candidates for organ preservation. Up to now, DWI and 18F-FDG PET/CT are not accurate enough to safely select patients for organ-sparing strategies. Future research must focus on the integration of functional imaging with clinical data and molecular biomarkers.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ines Joye, Christophe M. Deroose, Vincent Vandecaveye, Karin Haustermans,